Journal profile · Allergy
Journal of Investigational Allergology and Clinical Immunology
ISSN 1018-9068 · eISSN 1698-0808 · Esmon Publicidad S.A. · SPAIN · Bimonthly · Founded 1991
Journal of Investigational Allergology and Clinical Immunology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 6.38; fully open access; APC charged, amount not published; review 6–12 weeks (community reports); community-reported acceptance: fairly easy; 91 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Investigational Allergology and Clinical Immunology is published by Esmon Publicidad S.A. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Food Allergy and Anaphylaxis Research, Allergic Rhinitis and Sensitization and Asthma and respiratory diseases, together about 38.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Investigational Allergology & Clinical Immunology will consider for publication those papers directly related to allergology and clinical and experimental immunopathology.
From the journal's Aims & Scope
Research area (LetPub): Allergy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Food Allergy and Anaphylaxis ResearchMedicine14.6%
- Allergic Rhinitis and SensitizationMedicine12.2%
- Asthma and respiratory diseasesMedicine12.1%
- Drug-Induced Adverse ReactionsMedicine10.3%
- Contact Dermatitis and AllergiesMedicine7.5%
- Urticaria and Related ConditionsMedicine6.2%
- Dermatology and Skin DiseasesMedicine3.8%
- Eosinophilic EsophagitisMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Allergy | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Allergy | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Allergy | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINECASCurrent ContentsPublisher website
Other: Current Biology, Database Subidase, IBECS, Pascal INIST
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.38LetPub ·
- Impact factor (publisher) 2025
- 6.6Publisher website ·
- CiteScore 2026-06
- 6.2LetPub ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 1.05LetPub ·
- h-index
- 55LetPub ·
- h-index
- 48OpenAlex ·
- i10-index
- 334OpenAlex ·
- 2-year mean citedness
- 1.31OpenAlex ·
- Self-citation rate
- 12.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 38LetPub ·
Articles by year OpenAlex count · 1,141 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 62 | 62 | 31 |
| 2025 | 91 | 91 | 100 |
| 2024 | 66 | 66 | 156 |
| 2023 | 100 | 100 | 547 |
| 2022 | 105 | 105 | 822 |
| 2021 | 115 | 115 | 1,058 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | EUR 500 | — | — |
Other charges and waivers (author guidelines)
- Page charges
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Manuscript length
- ≤ 3,500 words
- Cover letter
- Required
Article types accepted5, with length limits
- letters to the editorLetters to the Editor. Comments on articles published in J Investig Allergol Clin Immunol are welcome.Length not stated
- original articlelegends, or references are as follows: original articles, 3500 words; reviews 6000; short communications, brief case notes and lmain text ≤ 3,500 words
- original articlesOriginal Articles. Original research papers in allergy and immunopathology, new forms of therapy for allergic and immune disorders, new applications of diagnost…Length not stated
- practitioner’s cornerPractitioner’s Corner. These short papers, which are intended for rapid publication, follow the same structures as longer original articles described above but …Length not stated
- review articlesReview Articles. Contributions from specialists in the field are encouraged. The journal welcomes the submission of narrative and systematic reviews that provid…Length not stated
Policy excerpts from the journal's websiteAI use, License & copyright, Open access, Plagiarism
- AI use
The JIACI is not opposed to using AI, but its use must be declared clearly and explicitly. Model summary
The JIACI is not opposed to using AI, but its use must be declared clearly and explicitly.
Source ↗Publisher website ·- License & copyright
Open access under the Creative Commons Attribution-NonCommercial 4.0 International Licence (CC BY-NC 4.0). Model summary
Open access under the Creative Commons Attribution-NonCommercial 4.0 International Licence (CC BY-NC 4.0).
Source ↗Publisher website ·- Open access
Open access under CC BY-NC 4.0 licence Model summary
Open access under the Creative Commons Attribution-NonCommercial 4.0 International Licence (CC BY-NC 4.0).
Source ↗Publisher website ·- Plagiarism
JIACI uses the services of a plagiarism screening software that verifies the originality of content submitted before publication. Model summary
JIACI uses the services of a plagiarism screening software that verifies the originality of content submitted before publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Esmon Publicidad S.A.
- Country or region
- SPAIN
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1991
- ISSN
- 1018-9068
- Electronic ISSN
- 1698-0808
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Journal of Investigational Allergology and Clinical Immunology
What CAS zone is Journal of Investigational Allergology and Clinical Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Investigational Allergology and Clinical Immunology is in Zone 3 of Medicine, and in Zone 3 of the minor category Allergy / Immunology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Investigational Allergology and Clinical Immunology?
The latest impact factor listed by LetPub is 6.38; CiteScore 6.2, h-index 48.
How long does peer review take at Journal of Investigational Allergology and Clinical Immunology?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Investigational Allergology and Clinical Immunology?
According to the journal's author guidelines: Manuscript length: ≤ 3,500 words; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Journal of Investigational Allergology and Clinical Immunology?
According to LetPub and DOAJ records, Journal of Investigational Allergology and Clinical Immunology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, CAS and Current Contents; that list has not been checked against each database.
Is Journal of Investigational Allergology and Clinical Immunology open access, and what is the APC?
Journal of Investigational Allergology and Clinical Immunology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .